App-based Pelvic Floor Muscle Training in Pregnant and Postnatal Women: A Prospective Cohort Study Exploring Factors Associated with Prevention and Improvement of Urinary Incontinence

Overview

Journal Health Sci Rep

Specialty General Medicine

Date 2022 Aug 24

PMID 36000079

Authors

Erika Lojdahl

Anna Lindam

Ina Asklund

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Pelvic floor muscle training (PFMT) is recommended for continent pregnant women and postnatal women experiencing urinary incontinence (UI). The app Tät® has been developed for the treatment of stress UI with a focus on PFMT. The aim of this study was to investigate factors associated with the improvement of incontinence symptoms and retained continence in pregnant and postnatal women who used the app.

Methods: A prospective cohort study was carried out based on user questionnaires from the app Tät®. We included pregnant and postnatal women who answered the inclusion questionnaire between June 19, 2019 and September 19, 2020. The questionnaire included questions about the frequency and amount of leakage, the impact that UI has on everyday life, and experienced improvements at follow-up. We analyzed factors associated with improvement and retained continence using logistic regression.

Results: We included 10,307 pregnant and 13,670 postnatal women, and 44% of the pregnant women and 52% of the postnatal women were incontinent. A total of 3680 women were included in the follow-up analysis, and 52% of the pregnant incontinent women and 73% of the postnatal incontinent women experienced improvement. Pregnant women who performed PFMT and used the app at least once per week had increased odds of improvement (odds ratio [OR]: 1.83, 95% confidence interval [CI]: 1.01-3.29 and OR: 3.38, 95% CI: 1.94-5.90, respectively) compared to those who performed no training and had no app usage. Postnatal women who used the app at least once per week and had more severe incontinence had increased odds of improvement (OR: 4.26, 95% CI: 2.37-7.64 and OR: 1.11, 95% CI: 1.05-1.16, respectively).

Conclusions: The app Tät® is widely used by pregnant and postnatal women in Sweden for the prevention and treatment of UI. Majority of the women with incontinence experienced improvement after using the app. Regular PFMT and app use seemed to be important factors for experiencing improvement.

Citing Articles

Pelvic Floor Muscle Training Using the Perifit Device for the Treatment of Urinary Incontinence: A Pragmatic Trial Using Real-World Data.

Perrier E, Aumont L Womens Health Rep (New Rochelle). 2024; 5(1):250-258.

PMID: 38516650 PMC: 10956527. DOI: 10.1089/whr.2023.0172.

App-based pelvic floor muscle training in pregnant and postnatal women: A prospective cohort study exploring factors associated with prevention and improvement of urinary incontinence.

Lojdahl E, Lindam A, Asklund I Health Sci Rep. 2022; 5(5):e781.

PMID: 36000079 PMC: 9387900. DOI: 10.1002/hsr2.781.

References

Hagglund D, Larsson G, Leppert J . Quality of life and seeking help in women with urinary incontinence. Acta Obstet Gynecol Scand. 2001; 80(11):1051-5. View

Labrie J, Lagro-Janssen A, Fischer K, Berghmans L, van der Vaart C . Predicting who will undergo surgery after physiotherapy for female stress urinary incontinence. Int Urogynecol J. 2014; 26(3):329-34. DOI: 10.1007/s00192-014-2473-z. View

Obloza A, Teo R, Marriott E, Parker G, Tincello D . Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women. Int Urogynecol J. 2018; 30(5):705-710. DOI: 10.1007/s00192-018-3778-0. View

Rygh P, Asklund I, Samuelsson E . Real-world effectiveness of app-based treatment for urinary incontinence: a cohort study. BMJ Open. 2021; 11(1):e040819. PMC: 7783523. DOI: 10.1136/bmjopen-2020-040819. View

Kinchen K, Burgio K, Diokno A, Fultz N, Bump R, Obenchain R . Factors associated with women's decisions to seek treatment for urinary incontinence. J Womens Health (Larchmt). 2003; 12(7):687-98. DOI: 10.1089/154099903322404339. View

Asklund I, Nystrom E, Sjostrom M, Umefjord G, Stenlund H, Samuelsson E . Mobile app for treatment of stress urinary incontinence: A randomized controlled trial. Neurourol Urodyn. 2016; 36(5):1369-1376. DOI: 10.1002/nau.23116. View

Schaffer J, Nager C, Xiang F, Borello-France D, Bradley C, Wu J . Predictors of success and satisfaction of nonsurgical therapy for stress urinary incontinence. Obstet Gynecol. 2012; 120(1):91-7. PMC: 3427534. DOI: 10.1097/AOG.0b013e31825a6de7. View

Haylen B, Ridder D, Freeman R, Swift S, Berghmans B, Lee J . An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2009; 29(1):4-20. DOI: 10.1002/nau.20798. View

Woldringh C, van den Wijngaart M, Albers-Heitner P, Lycklama A Nijeholt A, Lagro-Janssen T . Pelvic floor muscle training is not effective in women with UI in pregnancy: a randomised controlled trial. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 18(4):383-90. DOI: 10.1007/s00192-006-0175-x. View

10.

Soave I, Scarani S, Mallozzi M, Nobili F, Marci R, Caserta D . Pelvic floor muscle training for prevention and treatment of urinary incontinence during pregnancy and after childbirth and its effect on urinary system and supportive structures assessed by objective measurement techniques. Arch Gynecol Obstet. 2019; 299(3):609-623. DOI: 10.1007/s00404-018-5036-6. View

11.

Thom D, Rortveit G . Prevalence of postpartum urinary incontinence: a systematic review. Acta Obstet Gynecol Scand. 2010; 89(12):1511-22. DOI: 10.3109/00016349.2010.526188. View

12.

Klovning A, Avery K, Sandvik H, Hunskaar S . Comparison of two questionnaires for assessing the severity of urinary incontinence: The ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn. 2009; 28(5):411-5. DOI: 10.1002/nau.20674. View

13.

Nystrom E, Soderstrom L, Samuelsson E . Self-management of incontinence using a free mobile app: factors associated with improvement. Int Urogynecol J. 2021; 33(4):877-885. PMC: 9021135. DOI: 10.1007/s00192-021-04755-5. View

14.

Burgio K, Goode P, Locher J, Richter H, Roth D, Wright K . Predictors of outcome in the behavioral treatment of urinary incontinence in women. Obstet Gynecol. 2003; 102(5 Pt 1):940-7. DOI: 10.1016/s0029-7844(03)00770-1. View

15.

Lindh A, Sjostrom M, Stenlund H, Samuelsson E . Non-face-to-face treatment of stress urinary incontinence: predictors of success after 1 year. Int Urogynecol J. 2016; 27(12):1857-1865. PMC: 5124436. DOI: 10.1007/s00192-016-3050-4. View

16.

Sjostrom M, Lindholm L, Samuelsson E . Mobile App for Treatment of Stress Urinary Incontinence: A Cost-Effectiveness Analysis. J Med Internet Res. 2017; 19(5):e154. PMC: 5440735. DOI: 10.2196/jmir.7383. View

17.

Nystrom E, Sjostrom M, Stenlund H, Samuelsson E . ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Neurourol Urodyn. 2014; 34(8):747-51. DOI: 10.1002/nau.22657. View

18.

Avery K, Donovan J, Peters T, Shaw C, Gotoh M, Abrams P . ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004; 23(4):322-30. DOI: 10.1002/nau.20041. View

19.

Woodley S, Lawrenson P, Boyle R, Cody J, Morkved S, Kernohan A . Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev. 2020; 5:CD007471. PMC: 7203602. DOI: 10.1002/14651858.CD007471.pub4. View

20.

ODonnell M, Lose G, Sykes D, Voss S, Hunskaar S . Help-seeking behaviour and associated factors among women with urinary incontinence in France, Germany, Spain and the United Kingdom. Eur Urol. 2005; 47(3):385-92. DOI: 10.1016/j.eururo.2004.09.014. View